Novo Nordisk (NVO)

Financial Performance

Novo Nordisk's latest reported revenue stands at $71.3B, marking a growth of 4.8% from the previous quarter and an annual increase of 8.3%. The gross profit is $60B, reflecting quarterly and yearly growth rates of 3.8% and 7.4%, respectively. Their operating income profit surged by 30.4% from the previous quarter to reach $33.8B, which is a significant year over year increase of 26.4%. The EBITDA ratio for the last quarter was recorded at 0.52.

Stock Price

The stock price currently sits at $83.21, which indicates a decrease of -22.2% over the past month and -21.8% on a YoY basis.The RSI value is currently at an oversold level of 33.57 suggesting potential for future gains while the stock's PE ratio stands at 28.59 which may indicate it being slightly overvalued based on earnings alone.

Alternative Data Signals

The company's website traffic has declined by -29.3% MoM and -20.6% YoY with an estimated visitor count standing at around 687325 per month.On the brighter side, Novo Nordisk appears to be in expansion mode as indicated by its job postings that have increased by almost 11% YoY with current open positions numbering around933 . Employee sentiment seems positive with approximately86 % reporting a positive business outlook.Social media followership shows mixed trends; Twitter followers have grown marginally (up by about4 % in last90 days), Instagram followers have seen substantial growth (up39 % in last90 days) whereas Facebook followers have increased by a minor1.7 % in last90 days.

Conclusion

Despite the recent downturn in stock price and website traffic, Novo Nordisk's strong financial performance, positive employee sentiment, and increasing social media followership make it a potentially good investment opportunity. However, investors must keep an eye on the declining stock price and RSI value. Overall, the analysis is cautiously optimistic or 'neutral' about Novo Nordisk's stock.

Note: This AI Stock Analysis is based on data as of January 15. Our members can refresh and get access to an up-to-date AI stock analysis.

Sign up

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novo Nordisk (NVO), currently trading at $79.31, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.